GH Research (GHRS) Cash from Investing Activities (2021 - 2025)

GH Research (GHRS) recorded quarterly Cash from Investing Activities of $8.8 million in Q4 2025, down 9.65% quarter-over-quarter from $9.8 million in Q3 2025, and down 58.56% on a YoY basis from $21.3 million in Q4 2024.

GH Research (GHRS) Cash from Investing Activities (2021 - 2025) Analysis & Trends

GH Research's Cash from Investing Activities history runs 5 years deep, the most recent figure standing at $8.8 million for Q4 2025.

  • In Q4 2025, Cash from Investing Activities fell 58.56% year-over-year to $8.8 million; the TTM figure through Dec 2025 stood at $46.2 million (down 29.11% YoY), while the FY2025 annual figure was $46.2 million, down 29.11% from the prior year.
  • Cash from Investing Activities was $8.8 million for Q4 2025 at GH Research, down from $9.8 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $21.3 million in Q4 2024 to a low of -$84.6 million in Q4 2022.
  • Historically, Cash from Investing Activities has averaged -$1.4 million across 5 years, with a median of -$12000.0 in 2021.
  • The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities tumbled 540120.0% in 2023, then jumped 191150.0% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$19000.0 in 2021, then slumped by 445368.42% to -$84.6 million in 2022, then jumped by 99.97% to -$24000.0 in 2023, then jumped by 88979.17% to $21.3 million in 2024, then plunged by 58.56% to $8.8 million in 2025.
  • The last three Cash from Investing Activities figures came in at $8.8 million (Q4 2025), $9.8 million (Q3 2025), and $15.7 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -2.89 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 638.50 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn -431.90 Mn
9 Abivax 94.26 Bn 94.26 Bn - 579,519.10
10 GH Research 9.73 Bn 9.63 Bn - 8.84 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 8.84 Mn
Dec 31, 2025 8.84 Mn
Sep 30, 2025 9.78 Mn
Sep 30, 2025 9.78 Mn
Jun 30, 2025 15.71 Mn
Jun 30, 2025 15.71 Mn
Mar 31, 2025 11.84 Mn
Mar 31, 2025 11.84 Mn
Dec 31, 2024 21.33 Mn
Dec 31, 2024 21.33 Mn
Sep 30, 2024 15.28 Mn
Sep 30, 2024 15.28 Mn
Jun 30, 2024 19.73 Mn
Jun 30, 2024 19.73 Mn
Mar 31, 2024 8.79 Mn
Mar 31, 2024 8.79 Mn
Dec 31, 2023 -24,000.00
Dec 31, 2023 -24,000.00
Sep 30, 2023 -8,000.00
Sep 30, 2023 -8,000.00